SAMSARA BIOCAPITAL, LLC MLYS Holdings History
SAMSARA BIOCAPITAL, LLC's Mineralys Therapeutics Inc Holding Summary
As of 2025-03-31, SAMSARA BIOCAPITAL, LLC held 5.67 Mil shares of Mineralys Therapeutics Inc(MLYS), totaling $90.12 Mil. This investment constitutes 16.07% of their stock portfolio, and SAMSARA BIOCAPITAL, LLC now holds 8.71% of the outstanding Mineralys Therapeutics Inc(MLYS) stock.
The initial trade took place in 2023Q1. And since then SAMSARA BIOCAPITAL, LLC has made 3 purchases of MLYS, at an average price of $15.83, for a total of 5.67 Mil shares. Based on historical transaction data and MLYS's current price of $14.49, SAMSARA BIOCAPITAL, LLC's estimated gain on his MLYS holdings is $-7.59 Mil, reflecting a -8.45% gain to date.
SAMSARA BIOCAPITAL, LLC MLYS ($14.49) Holding Chart
SAMSARA BIOCAPITAL, LLC MLYS ($14.49) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
